In: Neurochemical Research, 2015, vol. 40, no. 12, p. 2639-2646
|
In: International Journal of Neuropsychopharmacology, 2016, vol. 19, no. 3, p. -
|
In: Schizophrenia Bulletin, 2018, vol. 44, no. 2, p. 317-327
|
In: Magnetic Resonance Materials in Physics, Biology and Medicine, 2015, vol. 28, no. 5, p. 485-492
|
In: Schizophrenia Bulletin, 2016, vol. 42, no. 5, p. 1185-1196
|
In: Plos one, 2011, vol. 6, no. 4, p. e18268
Background: Monoclonal antibodies and antibody fragments are powerful biotherapeutics for various debilitating diseases. However, high production costs, functional limitations such as inadequate pharmacokinetics and tissue accessibility are the current principal disadvantages for broadening their use in clinic. Methodology and Principal Findings: We report a novel method for the long-term ...
|
In: Metabolomics, 2014, vol. 10, no. 5, p. 986-994
|
In: Magnetic Resonance Materials in Physics, Biology and Medicine, 2008, vol. 21, no. 1-2, p. 53-61
|
In: Magnetic Resonance Materials in Physics, Biology and Medicine, 2009, vol. 22, no. 1, p. 1-4
|
In: The Cerebellum, 2012, vol. 11, no. 2, p. 384-391
|